RainDance Technologies was one of six projects funded for a total of $3.7 million, and was selected out of a total of twenty seven that were submitted for consideration by the MLSC. The awards will be matched dollar-for-dollar by the industry partners involved with each collaboration.
The grants were created to fund collaborations between scientists, academic institutions and industry that "promise significant commercial potential in the near term and are scientifically meritorious," according to the MLSC.
About RainDance Technologies, Inc.
RainDance Technologies Inc. is a provider of innovative microdroplet-based solutions for human health and disease research. The speed and simplicity of the company's exciting new technology platform enable researchers to design experiments in ways that were previously unaffordable or unimaginable. The company's RainStorm(TM) technology produces picoliter-volume droplets at a rate of 10 million per hour. Each droplet is the functional equivalent of an individual test tube and can contain a single molecule, reaction, or cell. This versatile technology can adapt proven assays for high-speed workflows with minimized process-induced bias or error.
RainDance's initial application will focus on the targeted resequencing of the human genome -- one of the fastest-growing segments of the $1 billion DNA sequencing market. This application will enable the high-resolution analysis of genetic variation between individuals and populations at a level unmatched by current methodology.
RainDance was founded in 2004 by scientists from
RainStorm(TM) is a trad
|SOURCE RainDance Technologies, Inc.|
Copyright©2009 PR Newswire.
All rights reserved